Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunfa Cheng

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|May 22, 2003
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformationSunfa Cheng, David H Lovett
The Biochemical Journal|May 16, 2002
Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1)Sunfa Cheng, Maria Alexandra Alfonso-Jaume, Peter R Mertens, et al.
Biochemical and Biophysical Research Communications|July 6, 2010
YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasisDavid H Lovett, Sunfa Cheng, Leslie Cape, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 8, 2006
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injurySunfa Cheng, Allan S Pollock, Rajeev Mahimkar, et al.
The Biochemical Journal|October 10, 2002
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersMarina R Bergman, Sunfa Cheng, Norman Honbo, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 21, 2021
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomesJohn Mark Stephens, Kathleen M Fox, Pooja Desai, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year studyMunro Peacock, Michael A Bolognese, Michael Borofsky, et al.
Headache|March 25, 2021
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraineFumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Journal of Cardiac Failure|October 9, 2012
Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTIONShelby D Reed, Yanhong Li, Stephen J Ellis, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2010
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severityMunro Peacock, J P Bilezikian, M A Bolognese, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|May 22, 2003
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformationSunfa Cheng, David H Lovett
The Biochemical Journal|May 16, 2002
Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1)Sunfa Cheng, Maria Alexandra Alfonso-Jaume, Peter R Mertens, et al.
Biochemical and Biophysical Research Communications|July 6, 2010
YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasisDavid H Lovett, Sunfa Cheng, Leslie Cape, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 8, 2006
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injurySunfa Cheng, Allan S Pollock, Rajeev Mahimkar, et al.
The Biochemical Journal|October 10, 2002
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersMarina R Bergman, Sunfa Cheng, Norman Honbo, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 21, 2021
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomesJohn Mark Stephens, Kathleen M Fox, Pooja Desai, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year studyMunro Peacock, Michael A Bolognese, Michael Borofsky, et al.
Headache|March 25, 2021
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraineFumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Journal of Cardiac Failure|October 9, 2012
Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTIONShelby D Reed, Yanhong Li, Stephen J Ellis, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2010
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severityMunro Peacock, J P Bilezikian, M A Bolognese, et al.
Pageof 5